Health In Tech, Inc. (HIT) — Institutional Holders, Q2 2026

21 institutional investment managers reported a HIT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

HIT in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

8

Added to

7

Trimmed

5

Sold out

2

Biggest buyers

  1. Whetstone Capital AdvisorsNew · +1,509,766 sh+$1.5M
  2. Mink Brook Asset ManagementAdded · +326,908 sh+$330.2K
  3. CITADEL ADVISORSAdded · +140,279 sh+$141.7K
  4. BlackRockAdded · +64,940 sh+$65.6K
  5. VANGUARD FIDUCIARYAdded · +55,914 sh+$56.5K

Biggest sellers

  1. TWO SIGMA INVESTMENTSSold out · -52,306 sh-$52.8K
  2. HEIGHTS CAPITAL MANAGEMENTTrimmed · -23,030 sh-$23.3K
  3. MORGAN STANLEYTrimmed · -13,747 sh-$13.9K
  4. Scientech ResearchSold out · -10,853 sh-$11.0K
  5. UBS Group AGTrimmed · -2,980 sh-$3.0K

HIT 13F holders ranked 1–21 of 21

Institutional investors reporting a position in Health In Tech, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Whetstone Capital Advisors#1 · 1,509,766 sh$1.5MNew
Mink Brook Asset Management#2 · 1,133,369 sh$1.1M+40.5%
VANGUARD CAPITAL MANAGEMENT#3 · 568,475 sh$574.2K+0.5%
HEIGHTS CAPITAL MANAGEMENT#4 · 350,268 sh$353.8K-6.2%
BlackRock#5 · 349,595 sh$353.1K+22.8%
GEODE CAPITAL MANAGEMENT#6 · 220,650 sh$222.9K+20.4%
CITADEL ADVISORS#7 · 176,911 sh$178.7K+382.9%
VANGUARD FIDUCIARY#8 · 130,482 sh$131.8K+75.0%
STATE STREET#9 · 62,900 sh$63.5K0.0%
NORTHERN#10 · 57,659 sh$58.2K+59.5%
XTX Topco Ltd#11 · 22,898 sh$23.1K-8.0%
TWO SIGMA SECURITIES#12 · 18,667 sh$18.9KNew
Virtu Financial#13 · 15,072 sh$15.0KNew
StoneX Group#14 · 14,264 sh$14.3KNew
LPL Financial#15 · 13,582 sh$13.7KNew
MN Wealth Advisors#16 · 12,000 sh$12.1KNew
Qube Research & Technologies Ltd#17 · 10,426 sh$10.5KNew
UBS Group AG#18 · 5,223 sh$5.3K-36.3%
Tower Research Capital (TRC)#19 · 3,263 sh$3.3K-28.4%
MORGAN STANLEY#20 · 962 sh$972.00-93.5%
BARCLAYS PLC#21 · 719 sh$726.00New

Funds that sold out of HIT in Q2 2026 (2)

Held HIT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held HIT in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
TWO SIGMA INVESTMENTS52,306 sh$75.8K
Scientech Research10,853 sh$15.7K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.